INHALED COLISTIN USE IN A NEUTROPENIC PATIENT.

Abstract Fifty nine years old man who was diagnosed as mantle cell lymphoma   relapsed after high dose chemotherapy with peripheral stem cell rescue. One course of R- Hyper CVAD regimen  followed by high dose metotreaxate and cytrabine regimen was applied. Seven days after therapy he had  neutrope...

Full description

Saved in:
Bibliographic Details
Main Authors: Figen Atalay, Aylin Ozsancak, Funda Timurkaynak
Format: Article
Language:English
Published: PAGEPress Publications 2014-08-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:https://mjhid.org/index.php/mjhid/article/view/1879
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846146628361125888
author Figen Atalay
Aylin Ozsancak
Funda Timurkaynak
author_facet Figen Atalay
Aylin Ozsancak
Funda Timurkaynak
author_sort Figen Atalay
collection DOAJ
description Abstract Fifty nine years old man who was diagnosed as mantle cell lymphoma   relapsed after high dose chemotherapy with peripheral stem cell rescue. One course of R- Hyper CVAD regimen  followed by high dose metotreaxate and cytrabine regimen was applied. Seven days after therapy he had  neutropenic fever, sepsis and he followed in intensive care units (ICU) with ventilation support. Sputum culture revealed multi-drug resistant Pseudomonas aeruginosa. Intravenous colistin  and meropenem  was started .Because of seven days after his condition did’nt improve, inhaled and intravenous colistin combination with meropenem was  used. Two  weeks  later this therapy, his pneumonia and septic situation were regression, he was clinically stable. Pseudomonas aeruginosa is a nosocomial  pathogen which generally causes infections  in  ICUs or immunocompromised patients. Prolonged neutropenia and mechanical ventilation increase the risk of lower respiratory tract infections due to Pseudomonas spp. Colistin   concentration is higher in sputum and lungs when it is used by inhalation and has more effective killing activity to the pathogens caused pneumonia. Aerolized colistin therapy concomitant with intravenous form may be an option for a successful treatment of infections due to these difficult to treat pathogens in these patients. Key Words: Pseudomonas Infections, Immunosuppression, Lymphoma, Mantle-Cell, Drug Resistance, Multiple, Bacterial
format Article
id doaj-art-e9e75dd3fbe240b0aa8486e4a7ab41e5
institution Kabale University
issn 2035-3006
language English
publishDate 2014-08-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-e9e75dd3fbe240b0aa8486e4a7ab41e52024-12-02T02:05:54ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062014-08-011INHALED COLISTIN USE IN A NEUTROPENIC PATIENT.Figen Atalay0Aylin Ozsancak1Funda Timurkaynak2Baskent University Istanbul Research CenterBaskent University Istanbul Research CenterBaskent University Istanbul Research CenterAbstract Fifty nine years old man who was diagnosed as mantle cell lymphoma   relapsed after high dose chemotherapy with peripheral stem cell rescue. One course of R- Hyper CVAD regimen  followed by high dose metotreaxate and cytrabine regimen was applied. Seven days after therapy he had  neutropenic fever, sepsis and he followed in intensive care units (ICU) with ventilation support. Sputum culture revealed multi-drug resistant Pseudomonas aeruginosa. Intravenous colistin  and meropenem  was started .Because of seven days after his condition did’nt improve, inhaled and intravenous colistin combination with meropenem was  used. Two  weeks  later this therapy, his pneumonia and septic situation were regression, he was clinically stable. Pseudomonas aeruginosa is a nosocomial  pathogen which generally causes infections  in  ICUs or immunocompromised patients. Prolonged neutropenia and mechanical ventilation increase the risk of lower respiratory tract infections due to Pseudomonas spp. Colistin   concentration is higher in sputum and lungs when it is used by inhalation and has more effective killing activity to the pathogens caused pneumonia. Aerolized colistin therapy concomitant with intravenous form may be an option for a successful treatment of infections due to these difficult to treat pathogens in these patients. Key Words: Pseudomonas Infections, Immunosuppression, Lymphoma, Mantle-Cell, Drug Resistance, Multiple, Bacterialhttps://mjhid.org/index.php/mjhid/article/view/1879Pseudomonas InfectionsImmunosuppressionLymphomaMantle-CellDrug ResistanceMultiple
spellingShingle Figen Atalay
Aylin Ozsancak
Funda Timurkaynak
INHALED COLISTIN USE IN A NEUTROPENIC PATIENT.
Mediterranean Journal of Hematology and Infectious Diseases
Pseudomonas Infections
Immunosuppression
Lymphoma
Mantle-Cell
Drug Resistance
Multiple
title INHALED COLISTIN USE IN A NEUTROPENIC PATIENT.
title_full INHALED COLISTIN USE IN A NEUTROPENIC PATIENT.
title_fullStr INHALED COLISTIN USE IN A NEUTROPENIC PATIENT.
title_full_unstemmed INHALED COLISTIN USE IN A NEUTROPENIC PATIENT.
title_short INHALED COLISTIN USE IN A NEUTROPENIC PATIENT.
title_sort inhaled colistin use in a neutropenic patient
topic Pseudomonas Infections
Immunosuppression
Lymphoma
Mantle-Cell
Drug Resistance
Multiple
url https://mjhid.org/index.php/mjhid/article/view/1879
work_keys_str_mv AT figenatalay inhaledcolistinuseinaneutropenicpatient
AT aylinozsancak inhaledcolistinuseinaneutropenicpatient
AT fundatimurkaynak inhaledcolistinuseinaneutropenicpatient